WASHINGTON, Dec. 10, 2013 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement today on the recent opinion offered by the Tennessee State Attorney General. The opinion, which investigates the legality of local municipal-wide prescription ordinances for cold and allergy medicine containing pseudoephedrine (PSE), concluded that existing state law supersedes any effort to legislate at the local level.
"CHPA commends Attorney General Cooper for carefully reviewing this important issue. We have always maintained that a prescription mandate for pseudoephedrine is a state issue. Local city-and county-wide mandates are not effective solutions to address the illegal purchase of pseudoephedrine-containing medicines and we look forward to working with the Tennessee legislature to find effective solutions to the illegal sale of PSE."
Several municipalities in Tennessee have already passed ordinances calling for a prescription mandate while others are currently debating similar legislation.
CHPA is the 132-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.
SOURCE Consumer Healthcare Products Association